We are honored and humbled to share that Genstler Eye Center has been featured in this month’s Administrative Eye Care Magazine. AE Magazine is a national publication, spotlighting the latest news, technology, and successes in the fields of optometry and ophthalmology.
Topeka, Kan. (April 1, 2021) – Genstler Eye Center is proud to announce and welcome Dr. Lance Eisenbarth as a new Doctor of Optometry. With over 12 years experience, Dr. Eisenbarth will be responsible for the management of ocular services in their Topeka location.
Topeka, Lawrence and Manhattan, Kan. (May 17, 2019) – Dr. Arla Genstler, founder and owner of Gentler Eye Center, recently announced that Stephen Hinton, MD has been made a shareholder of Genstler Eye Center. Dr. Hinton has been with Genstler Eye Center for more than three years. “His knowledge, skill, ability and character are well suited to ensure that Genstler Eye Center continues to impact the communities that we serve long into the future,” states Dr Genstler.
Advancing the Options for Eye Care for Their Patients
Topeka, Lawrence and Manhattan, Kan. (May 17, 2019) – Arla Genstler, MD of Genstler Eye Center recently placed a bilateral toric Implantable Collamer Lens (ICL) in a patient. This was the first time this procedure has been done in the local region. “I am pleased to provide this technology to our area’s patients,” said Arla Genstler, MD. “This is a great option for individuals with high amounts of myopia with astigmatism who are not necessarily good candidates for LASIK surgery.”
Lawrence, Kan. (April 6, 2017) – Genstler Eye Center recently opened to its newest location at 4505 W Sixth Street, Suite C in Lawrence, Kansas. Dr. Stephen Hinton will be the primary staff physician in the Lawrence office.
Topeka, Lawrence and Manhattan, Kan. (April 4, 2019) – The LenSx femtosecond laser brings an elevated level of safety and accuracy to cataract surgery. Genstler Eye Center has invested in this cataract laser technology to expand the options available for its patients. This is the preferred treatment choice for cataract patients with low levels of astigmatism.